PanGraf 2.0 contains Tacrolimus 2.0 mg, an immunosuppressive medicine primarily used to help prevent organ rejection following transplantation. It is generally used as part of a combination immunosuppressive regimen and requires careful medical monitoring. Product Details Specification Details Brand Name PanGraf 2.0 Generic Name Tacrolimus Strength 2.0 mg Dosage Form Capsules Standard IP Category Immunosuppressants Therapeutic Area Transplantation Drug Class Calcineurin Inhibitor Product Overview Tacrolimus is a calcineurin inhibitor that suppresses immune-system activity. By reducing T-cell activation, it helps decrease the immune response responsible for attacking a transplanted organ. PanGraf 2.0 is therefore used under specialist supervision in transplant patients as part of an individualized immunosuppressive treatment plan. Uses & Indications Tacrolimus may be prescribed to help prevent rejection following: Kidney transplantation Liver transplantation Heart transplantation The exact indication and treatment regimen depend on the transplant type, patient characteristics, other immunosuppressive medicines, and local prescribing guidance. How Does Tacrolimus Work? Tacrolimus binds to intracellular proteins and inhibits calcineurin, reducing the production of cytokines involved in T-cell activation. This suppresses the immune response and helps reduce the likelihood of transplant rejection. Key Features & Benefits Contains Tacrolimus 2.0 mg Oral capsule formulation Calcineurin inhibitor Used in specialized transplant medicine Available for pharmaceutical sourcing and export, subject to applicable regulations Dosage & Administration Tacrolimus has a narrow therapeutic index, meaning blood concentrations need to be carefully controlled. The dosage is individualized according to the type of transplant, clinical response, tacrolimus blood levels, kidney and liver function, and interacting medicines. PanGraf 2.0 should be taken strictly according to the prescribing physician's instructions. Do not adjust the dose or discontinue treatment without medical advice. Important Safety Information Tacrolimus can cause significant adverse effects, including: Kidney toxicity High blood pressure Increased blood glucose Tremor and other neurological effects Increased susceptibility to infections Electrolyte abnormalities Increased risk of certain malignancies Regular monitoring of tacrolimus blood levels, kidney function, blood pressure, blood glucose, and electrolytes may be required. Tacrolimus also has numerous potential drug and food interactions. Patients should inform their healthcare professional about all medicines, supplements, and herbal products they use. Storage Store PanGraf 2.0 according to the manufacturer's labelled storage conditions. Keep the capsules in their original packaging and out of reach of children. Product Category Main Category: Immunosuppressants Subcategory: Transplant Medicines Drug Class: Calcineurin Inhibitor Therapeutic Area: Organ Transplantation Why Choose MEDINDIA EXPORT? MEDINDIA EXPORT supports pharmaceutical sourcing and international medicine export requirements for eligible markets. We assist buyers with product availability, quotations, documentation, and shipping arrangements, subject to destination-country regulations. 🌐 Website: www.medicineindiaexport.com 📧 Email: sales.medindiaexport@gmail.com 📱 WhatsApp: +91 7218129896 Frequently Asked Questions 1. What is PanGraf 2.0? PanGraf 2.0 is a capsule containing Tacrolimus 2.0 mg, an immunosuppressive medicine. 2. What is Tacrolimus 2 mg used for? Tacrolimus is primarily used as part of immunosuppressive therapy to help prevent rejection of transplanted organs. 3. Which category does PanGraf 2.0 belong to? It belongs to the Immunosuppressants / Transplant Medicines category and is classified as a calcineurin inhibitor. 4. Does Tacrolimus require monitoring? Yes. Because tacrolimus has a narrow therapeutic range, healthcare professionals commonly monitor blood concentrations along with kidney function and other clinical parameters. 5. Can Tacrolimus be stopped suddenly? Patients should not stop tacrolimus without medical advice, as inadequate immunosuppression can increase the risk of transplant rejection. 6. Can MEDINDIA EXPORT supply PanGraf 2.0 internationally? Product availability, export documentation, and shipment eligibility depend on the destination country's regulations and import requirements. Contact MEDINDIA EXPORT for current sourcing information.